Brain-derived neurotrophic factor (BDNF) promotes the survival of fetal mesencephalic dopaminergic cells and protects dopaminergic neurons against the toxicity of MPP+ in vitro. Supranigral implantation of fibroblasts genetically engineered to secrete BDNF attenuates the loss of substantia nigra pars compacta (SNc) dopaminergic neurons associated with striatal infusion of MPP+ in the adult rat. Using this MPP+ rat model of nigral degeneration, we evaluated the neurochemical effects of supranigral, cell-mediated delivery of BDNF on substantia nigra (SN) dopamine (DA) content and turnover. Genetically engineered BDNF-secreting fibroblasts (~12 ng BDNF/24 h) were implanted dorsal to the SN 7 days prior to striatal MPP+ administration. The present results demonstrate that BDNF-secreting fibroblasts, as compared to control fibroblasts, enhance SN DA levels ipsilateral as well as contralateral to the graft without altering DA turnover. This augmentation of DA levels suggests that local neurotrophic factor delivery by genetically engineered cells may provide a therapeutic strategy for preventing neuronal death or enhancing neuronal function in neurodegenerative diseases characterized by dopaminergic neuronal dysfunction, such as Parkinson's disease.
AltarC.A.BoylanC.B.FritscheM.JonesB.E.JacksonC.WiegandS.J.LindsayR.M.HymanC.Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions.J. Neurochem.63: 1021–1032; 1994.
2.
AltarC.A.BoylanC.B.JacksonC.HershensonS.MillerJ.WiegandS.J.LindsayR.M.HymanC.Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo.Proc. Natl. Acad. Sci. USA89: 11347–11351; 1992.
3.
AltarC.A.FritscheM.HoistP.RadkeS.Presence of BDNF protein in brain and plasma detected by a sensitive and specific enzyme-linked immunoassay.Soc. Neurosci. Abstr.21: 37; 1995.
4.
AltarC.A.SiuciakJ.A.WrightP.IpN.Y.LindsayR.M.WiegandS.J.In situ hybridization of trkB and trkC receptor mRNA in rat forebrain and association with high-affinity binding of [125I]BDNF, [125I]NT-4/5, and [125I]NT-3.Eur. J. Neurosci.6: 1389–1405; 1994.
5.
BealM.F.MatsonW.R.SwartzK.J.GamacheP.H.BirdE.D.Kynurenine pathway measurements in Huntington's disease striatum: Evidence for reduced formation of kynurenic acid.J. Neurochem.55: 1327–1339; 1990.
6.
BeckK.D.KnuselB.WinslowJ.W.RosenthalA.BurtonL.E.NikolicsK.HeftiF.Pretreatment of dopaminergic neurons in culture with brain-derived neurotrophic factor attenuates toxicity of 1-methyl-4-phenylpyridinium.Neurodegeneration1: 27–36; 1992.
7.
BeckK.D.ValverdeJ.AlexiT.PoulsenK.MoffatB.VandlenR.A.RosenthalA.HeftiF.Mesencephalic dopaminergic neurons protected by GDNF from axotomy- induced degeneration in the adult brain.Nature373: 339–341; 1995.
8.
CampbellK.J.TakadaM.HattoriT.Evidence for retrograde axonal transport of MPP+ in the rat.Neurosci. Lett.118: 151–154; 1990.
9.
ChirgwinJ.M.BrzybylaA.E.MacdonaldR.J.RutterW.J.Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.Biochemistry18: 5294–5299; 1979.
10.
EmerichD.F.HammangJ.P.BaetgeE.E.WinnS.R.Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections in rodent striatum.Exp. Neurol.130: 141–150; 1994.
11.
FrimD.M.EmanuelR.L.RobinsonB.G.SmasC.M.AdlerG.K.MajzoubJ.A.Characterization and gestational regulation of corticotropin-releasing hormone and messenger RNA in the human placenta.J. Clin. Invest.82: 293–299; 1988.
12.
FrimD.M.ShortM.P.BreakefieldX.O.IsacsonO.Biological gene-product delivery to the brain: A protocol for retroviral gene transfer into cultured cells and intracerebral transplantation.Neuroprotocols: A Companion to Methods in Neurosciences3: 63–68; 1993.
13.
FrimD.M.UhlerT.A.GalpernW.R.BealM.F.BreakefieldX.O.IsacsonO.Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.Proc. Natl. Acad. Sci. USA91: 5104–5108; 1994.
14.
FrimD.M.UhlerT.A.ShortM.P.EzzedineZ.D.KlagsbrunM.BreakefieldX.O.IsacsonO.Effects of biologically delivered NGF, BDNF, and bFGF in striatal excitotoxic lesions.Neuroreport4: 367–370; 1993.
15.
GallC.M.GoldS.J.IsacksonP.J.SeroogyK.B.Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons.Mol. Cell. Neurosci.3: 56–63; 1992.
16.
HaggT.Neurotrophins (BDNF, NT-3, NT-4) prevent death of axotomized adult rat substantia nigra neurons.Soc. Neurosci. Abstr.20: 441; 1994.
17.
HaggT.ManthorpeM.VahlsingH.L.VaronS.Delayed treatment with nerve growth factor reverses the apparent loss of cholinergic neurons after acute brain damage.Exp. Neurol.101: 303–312; 1988.
18.
HeftiF.Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections.J. Neurosci.6: 2155–2162; 1986.
19.
HeftiF.Neurotrophic factor therapy for nervous system degenerative diseases.J. Neurobiol.25: 1418–1435; 1994.
20.
HymanC.HoferM.BardeY.-A.JuhaszM.YancopoulosG.D.SquintoS.P.LindsayR.M.BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra.Nature350: 230–232; 1991.
21.
HymanC.JuhaszMLJacksonC.WrightP.IpN.Y.LindsayR.M.Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon.Neuroscience14: 335–347; 1994.
22.
IsacsonO.BrundinP.GageF.H.BjörklundA.Neural grafting in a rat model of Huntington's disease: Progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting.Neuroscience16: 799–817; 1985.
KennedyT.E.SerafiniT.de la TorreJ.R.Tessier-LavigneM.Netrins are diffusible chemotropic factors for commissural axons in the embryonic spinal cord.Cell787: 425–435; 1994.
25.
KnuselB.BeckK.D.WinslowJ.W.RosenthalA.BurtonL.E.WidmerH.R.NikolicsK.HeftiF.Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain.J. Neurosci.12: 4391–4402; 1992.
26.
KnuselB.WinslowJ.W.RosenthalA.BurtonL.E.SeidD.P.NikolicsK.HeftiF.Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin-3.Proc. Natl. Acad. Sci. USA88: 961–965; 1991.
LamsB.E.IsacsonO.SofroniewM.V.Loss of transmitter-associated enzyme staining following axotomy does not indicate death of brainstem cholinergic neurons.Brain Res.475: 401–406; 1988.
29.
LapchakP.A.BeckK.D.AraujoD.M.IrwinI.LangstonJ.W.HeftiF.Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.Neuroscience53: 639–650; 1993.
30.
LehrachH.DiamondD.WozneyJ.M.BoedtkerH.RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination.Biochemistry16: 4743–4751; 1977.
31.
LindsayR.M.AltarC.A.CedarbaumJ.M.HymanC.WiegandS.J.The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.Exp. Neurol.124: 103–118; 1993.
32.
Martin-IversonM.T.ToddK.G.AltarC.A.Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: Interactions with amphetamine.J. Neurosci.14: 1262–1270; 1994.
33.
MerlioJ.-P.ErnforsP.JaberM.PerssonH.Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system.Neuroscience51: 513–532; 1992.
34.
MorseJ.K.WiegandS.J.AndersonK.YouY.CaiN.CarnahanJ.MillerJ.DiStefanoP.S.AltarC.A.LindsayR.M.AldersonR.F.Brain-derived neurotrophic afactor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection.J. Neurosci.13; 4146–4156: 1993.
35.
MufsonE.J.KroinJ.S.SobrevielaT.BurkeM.A.KordowerJ.H.PennR.D.MillerJ.A.Intrastriatal infusions of brain-derived neurotrophic factor: Retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat.Exp. Neurol.129: 15–26; 1994.
36.
NicklasW.J.YoungsterS.K.KindtM.V.HeikkilaR.E.MPTP, MPP+ and mitochondrial function.Life Sci.40: 721–729; 1987.
37.
RosenbergM.B.FriedmannT.RobertsonR.C.TuszynskiM.WolffJ.A.BreakefieldX.O.GageF.H.Grafting genetically modified cells to the damaged brain: Restorative effects of NGF expression.Science242: 1575–1578; 1988.
38.
SauerH.FischerW.NikkhahG.WiegandS.J.BrundinP.LindsayR.M.BjorklundA.Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts.Brain Res.626: 37–44; 1993.
39.
SchumacherJ.M.ShortM.P.HymanB.T.BreakefieldX.O.IsacsonO.Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids.J. Neurosci.45: 561–570; 1991.
40.
SerafiniT.KennedyT.E.GalkoM.J.MirzayanC.JessellT.M.Tessier-LavigneM.The netrins define a family of axon outgrowth-promoting proteins homologous to C.elegans UNC-6. Cell78: 409–424; 1994.
41.
SeroogyK.B.LundgrenK.H.TranT.M.D.GuthrieK.M.IsacksonP.J.GallC.M.Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs.J. Comp. Neurol.342: 321–334; 1994.
42.
ShenR.-Y.AltarC.A.ChiodoL.A.Brain-derived neurotrophic factor increase the electrical activity of pars compacta dopamine neurons in vivo.Proc. Natl. Acad. Sci. USA91: 8920–8924; 1994.
43.
SpinaM.B.SquintoS.P.MillerJ.LindsayR.M.HymanC.Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: Involvement of the glutathione system.J. Neurochem.59: 99–106; 1992.
44.
SrivastavaR.BrouilletE.BealM.F.StoreyE.HymanB.T.Blockade of 1-mefhyl-4-phenylpyridinium ion (MPP+) nigral toxicity in the rat by prior decortication or MK-801 treatment: A stereological estimate of neuronal loss.Neurobiol. Aging14: 295–301; 1993.
45.
TakayamaH.RayJ.RaymonH.K.BairdA.HoggJ.FisherL.J.GageF.H.Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease.Nature Med.1: 53–58; 1995.
46.
TomacA.LindqvistE.LinL.-F.H.ögrenS.O.YoungD.HofferB.J.OlsonL.Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo.Nature373: 335–339; 1995.
47.
VejsadaR.SagotY.KatoA.C.BDNF-mediated rescue of axotomized motor neurones decreases with increasing dose.Neuroreport5: 1889–1892; 1994.
48.
VeneroJ.L.BeckK.D.HeftiF.Intrastriatal infusion of nerve growth factor after quinolinic acid prevents reduction of cellular expression of choline acetyltransferase messenger RNA and trkA messenger RNA, but not glutamate decarboxylase messenger RNA.Neuroscience61: 257–268; 1994.
49.
WilliamsL.R.VaronS.PetersonG.M.WictorinK.FischerW.BjorklundA.GageF.H.Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection.Proc. Natl. Acad. Sci. USA83: 9231–9235; 1986.
50.
WolfD.Richter-LandsbergC.ShortM.P.CepkoC.BreakefieldX.O.Retrovirus-mediated gene transfer of beta-nerve growth factor into mouse pituitary line AtT-20.Mol. Biol. Med.5: 43–59; 1988.
